Product Information
RIVASTIGMINE 1.5 MG CAPSULE is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.1508 per EA under NDC 62756014586. Its NADAC has been published 639 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the Rivastigmine Tartrate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
1.5 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
62756014586
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
2/18/2026
Active Ingredients
RIVASTIGMINE TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA077131On Market Since
7/1/2010
Pharmacological Classes
Price Statistics
The NADAC for RIVASTIGMINE 1.5 MG CAPSULE has been published 639 times since Nov 28, 2013, and over the history we have for it it has declined 91.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1508 per EA |
|---|---|
| All-time high | $1.8587 (Mar 12, 2014) |
| All-time low | $0.1380 (Nov 22, 2023) |
| 52-week high | $0.1894 |
| 52-week low | $0.1458 |
| Median price | $0.3691 |
| Average price | $0.6402 |
| Largest weekly change | +49.6% (Oct 19, 2022) |
| Weeks tracked | 639 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RIVASTIGMINE 1.5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for RIVASTIGMINE 1.5 MG CAPSULE, manufactured by Sun Pharmaceutical Industries Inc., is $0.1508 per EA (NDC 62756014586), effective Feb 18, 2026.
How has the price of RIVASTIGMINE 1.5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for RIVASTIGMINE 1.5 MG CAPSULE has declined 91.6%. It has been tracked across 639 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for RIVASTIGMINE 1.5 MG CAPSULE?
Since Nov 28, 2013, the NADAC for RIVASTIGMINE 1.5 MG CAPSULE has ranged from a low of $0.1380 (Nov 22, 2023) to a high of $1.8587 (Mar 12, 2014), with a median of $0.3691 per EA.
Are there cheaper alternatives to RIVASTIGMINE 1.5 MG CAPSULE?
8 NADAC-published products share the same active ingredient, strength, and dosage form as RIVASTIGMINE 1.5 MG CAPSULE, but none are currently priced below it.
Who manufactures RIVASTIGMINE 1.5 MG CAPSULE?
RIVASTIGMINE 1.5 MG CAPSULE (NDC 62756014586) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification